As we approach 2025 , France is preparing to revise its mandatory vaccination policy, focusing particularly on seniors and at-risk individuals. The objective is to mitigate the severe forms of infectious diseases and limit preventable hospitalizations. This shift comes in response to a growing awareness of the vulnerability of certain groups to respiratory infections, particularly highlighted by the COVID-19 pandemic , which underscored the fragility of some populations.
Special Attention for the Most Vulnerable
The pandemic clearly illustrated the need to broaden the scope of vaccination to better protect older adults from respiratory infections, as per the definition of seniors. Organizations such as the General Directorate of Health (DGS) and the High Authority of Health (HAS) have already implemented new measures to bolster these recommendations. The goal is straightforward: to better protect those who need it most. This includes individuals over 60 years old , immunocompromised patients, those with chronic illnesses, and residents of EHPADs (nursing homes) or medical-social establishments, which also pertains to the professional inclusion of seniors .
According to these new guidelines, an annual booster shot against COVID-19 will become mandatory for individuals over 65 , high-risk patients, and healthcare professionals, aimed at maintaining a high level of protection. Furthermore, the shingles vaccine will be recommended starting at age 60 , particularly for those with existing health issues. Coverage of the pneumococcal vaccine will also be strengthened with the introduction of the 20-valent conjugate vaccine .
Facilitated Access and Improved Coverage
To streamline access to these vaccines, the vaccination pathway will undergo significant changes. Pharmacies will be transformed into genuine vaccination points, which is expected to help increase the number of vaccines administered. There are also plans to expand the roles of pharmacists, nurses, and midwives, allowing them to administer vaccines, thus making access easier for everyone.
Regarding the cost of certain expensive vaccines like Shingrix , coverage will be better facilitated. Moreover, awareness campaigns are set to launch, encouraging everyone to keep up with their booster shots.
Combatting Vaccine Fatigue
Despite all these efforts, a major challenge remains: addressing the issue of insufficient vaccination coverage . In 2023 , less than 40% of eligible French citizens received their booster for COVID-19. Similarly, the vaccination rate for shingles continues to lag. Therefore, the 2025 vaccination calendar aims to improve not only medical prevention but also its human and logistical aspects.
Over time, the immune system of seniors becomes less effective, emphasizing the urgency of vaccinating these populations to prevent complications that could lead to hospitalizations or a loss of autonomy.
In conclusion, the 2025 vaccination calendar marks a critical advancement for the protection of vulnerable individuals in France. By strengthening recommendations and enhancing the accessibility of vaccinations, this initiative aims to significantly reduce the risk of infectious complications among seniors. For those impacted, this poses a vital medical and social challenge that warrants serious attention.